-transparent.png){kind=logo}
The management of low grade lymphoma, both de novo and relapsed disease, is a contentious area in which there has been little real progress in recent years. Regimens which increase the intensity of treatment may accelerate the response but are inevitably associated with greater toxicity. This cannot be justified in a disease whose median survival is between 4 and 10 years and where the median age at presentation is 57. We have assessed the response of 144 patients treated with a combination of mitoxantrone, chlorambucil and prednisolone in a heterogeneous group with lymphoma, both de novo and relapsed disease. In the subgroup with low grade relapsed/refractory disease our results suggest that this combination is clinically effective, low in toxicity and suitable for the outpatient management of this usually elderly patient population.
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
February 2005,
Onkologie,
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
December 1987,
Cancer treatment reports,
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
January 1987,
Investigational new drugs,
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
February 1995,
Seminars in oncology,
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
April 2002,
Oncology (Williston Park, N.Y.),
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
June 1987,
Cancer treatment reports,
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
January 1988,
Oncology,
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
April 1993,
The Netherlands journal of medicine,
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
May 1991,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Bernard, and
S A Johnson, and
A G Prentice, and
L Jones, and
M J Phillips, and
A C Newland
January 1988,
Cancer treatment reviews,
